Anders Svensson is welcomed to the TikoMed board

Written on 2017-06-12

Anders Svensson, MD, PhD, Associate Professor of Medicine at University of Gothenburg has accepted to join the TikoMed board

Anders has a long career in the global pharmaceutical industry, with the last 13-plus years in senior positions (Vice President at Astra Zeneca, Global Head at Roche) with responsibility for developing and implementing portfolio strategies, research programmes and clinical studies. In his career Anders has had had frequent interactions with regulatory authorites, including FDA and EMA, and developed a global network of experts and opinion leaders.

Anders joins at a very exciting time as TikoMed is planning to initiate a series of clinical trials, based on a series of favorable animal studies.

“We are thrilled to have Anders joining with his capacity and experience. Anders also brings a large network from his earlier positions to TikoMed.” says Stefan Sallerfors, Chairman of the Board.

“I have personal experience from working with Anders Svensson for the last few years and it is always a pleasure. He brings insights and a thorough understanding of pharma development to our board. Adding his competence to the board makes our team complete.” says Adam Bruce, CEO.